Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight. (2017)
Attributed to:
Reducing relapse in alcohol dependence with the NMDA receptor antagonist, ketamine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2215-0366(17)30102-5
PubMed Identifier: 28395988
Publication URI: http://europepmc.org/abstract/MED/28395988
Type: Journal Article/Review
Volume: 4
Parent Publication: The lancet. Psychiatry
Issue: 5
ISSN: 2215-0366